Sfoglia per Autore
Expression of IAPs (Inhibitory of Apoptosis Proteins) and of their alternative splice variants in hepatocellular carcinoma tissues and cells
2004-01-01 NOTARBARTOLO DI VILLAROSA, M; CERVELLO, M; GIANNITRAPANI, L; MELI, M; POMA, P; DUSONCHET, L; MONTALTO, G; D'ALESSANDRO, N
Induction of apoptosis by the proteasome inhibitor MG132 in human HCC cells: Possible correlation with specific caspase-dependent cleavage of β-catenin and inhibition of β-catenin-mediated transactivation
2004-01-01 CERVELLO, M; GIANNITRAPANI, L; LA ROSA, M; NOTARBARTOLO DI VILLAROSA, M; LABBOZZETTA, M; POMA, P; MONTALTO, G; D'ALESSANDRO, N
Expression of the IAPs in multidrug resistant tumor cells
2004-01-01 NOTARBARTOLO M; CERVELLO M; POMA P; DUSONCHET L; MELI M; D'ALESSANDRO N
Induction of apoptosis and inhibition of cell growth in human hepatocellular carcinoma cells by COX-2 inhibitors
2004-01-01 FODERA' D; D; D'ALESSANDRO N; CUSIMANO A; POMA P; NOTARBARTOLO M; LAMPIASI N; MONTALTO G; CERVELLO M
Induction of apoptosis by the adenosine derivative IB-MECA in parental or multidrug-resistant HL-60 leukemia cells: possibile relationship to the effects on inhibitor of apoptosis protein levels
2005-01-01 NOTARBARTOLO DI VILLAROSA, M; LO CICERO, S; MELI, M; POMA, P; LABBOZZETTA, M; CERVELLO, M; D'ALESSANDRO, N
ANTITUMOR EFFECTS OF CURCUMIN, ALONE OR IN COMBINATION WITH CISPLATIN OR DOXORUBICIN, ON HUMAN HEPATIC CANCER CELLS. ANALYSIS OF THEIR POSSIBLE RELATIONSHIP TO CHANGES IN NF-KB ACTIVATION LEVELS AND IAP GENE EXPRESSION
2005-01-01 NOTARBARTOLO DI VILLAROSA, M; POMA, P; PERRI, D; DUSONCHET, L; CERVELLO, M; D'ALESSANDRO, N
New trends in overcoming drug resistance in hepatocellular carcinoma. Looking for pharmacological inhibition of Inhibitory of Apoptosis Proteins (IAPs) by curcumin.
2005-01-01 D'ALESSANDRO N; POMA P; PERRI D; LABBOZZETTA M; MELI M; CUSIMANO A; CERVELLO M; NOTARBARTOLO DI VILLAROSA M; Maria, M.
"Antitumor effects of the novel NF-kB inhibitor dehydroxymethylepoxyquinomicin (DHMEQ) on human hepatic cancer cells: analysis of synergy with cisplatin and of possible correlation with inhibition of pro-survival genes and IL-6 production”.
2006-01-01 POMA P; NOTARBARTOLO DI VILLAROSA, M; LABBOZZETTA M; SANGUEDOLCE R; ALAIMO A; CARINA V; MAURICI A; CUSIMANO A; CERVELLO M; D'ALESSANDRO N
Significance of autologous interleukin 6 production in the HA22T/VGH model of hepatocellular carcinoma
2006-01-01 LABBOZZETTA M; NOTARBARTOLO M; POMA P; GIANNITRAPANI L; CERVELLO M; MONTALTO G; D'ALESSANDRO N
Significance of Autologous Interleukin-6 Production in the HA22T/VGH Cell Model of Hepatocellular Carcinoma
2006-01-01 MANUELA LABBOZZETTA, MONICA NOTARBARTOLO,PAOLA POMA, LYDIA GIANNITRAPANI,MELCHIORRE CERVELLO,GIUSEPPE MONTALTO AND NATALE D’ALESSANDRO
“Antitumor and molecular effects of curcumin and of its isoxazole analogue on multidrug resistant breast cancer cells. New perspectives in tumor theraphy: molecular aspects, 2006”.
2006-01-01 POMA P; NOTARBARTOLO M; LABBOZZETTA M; MAURICI A; CARINA V; ALAIMO A; RIZZI M; SIMONI D; DALESSANDRO N
Plant polyphenols as privileged multi-target compounds for chemo- and immuno-sensitization
2006-01-01 D'ALESSANDRO N; POMA P
The antitumor activities of curcumin and its isoxazole analogue are not affected by multiple gene expression changes in an MDR model of the MCF-7 brest cancer cell line: Analysis of the possible molecular basis.
2007-01-01 POMA P; NOTARBARTOLO M; LABBOZZETTA M; MAURICI M; CARINA V; ALAIMO A; RIZZI M; SIMONI D; D'ALESSANDRO N
Multifactorial nature of hepatocellular carcinoma drug resistance: Could plant polyphenols be helpful?
2007-01-01 D'ALESSANDRO N; POMA P; MONTALTO G
Antitumor effects of curcumin and structurally beta-diketone modified analogs on multidrug resistant cancer cells
2008-01-01 SIMONI, D; RIZZI, M; RONDANIN, R; BARUCHELLO, R; MARCHETTI, P; INVIDIATA, F; LABBOZZETTA, M; POMA, P; CARINA, V; NOTARBARTOLO DI VILLAROSA, M; ALAIMO, A; D'ALESSANDRO, N
The effect of CYP3A5 and ABCB1 single nucleotide polymorphisms on tacrolimus dose requirements in Caucasian liver transplant patients
2009-01-01 PROVENZANI ALESSIO; NOTARBARTOLO M; LABBOZZETTA M; POMA P; BIONDI F; SANGUEDOLCE R; VIZZINI G; PALAZZO U; POLIDORI P; TRIOLO F; GRIDELLI B; D'ALESSANDRO N
Lack of nucleophilic addition in the isoxazole and pyrazole diketone modified analogs of curcumin; implications for their antitumor and chemosensitizing activities.
2009-01-01 Labbozzetta, M; Baruchello, R; Marchetti, P; Gueli, MC; Poma, P; Notarbartolo Di Villarosa, M; Simoni, D; D'Alessandro, N
Curcumin as a possible lead compound against hormone-independent, multidrug-resistant breast cancer
2009-01-01 LABBOZZETTA, M; NOTARBARTOLO DI VILLAROSA, M; POMA, P; MAURICI, A; INGUGLIA, L; MARCHETTI, P; RIZZI, M; BARUCHELLO, R; SIMONI, D; D'ALESSANDRO, N
Apollon gene silencing induces apoptosis in breast cancer cells via p53 stabilisation and caspase-3 activation
2009-01-01 LOPERGOLO, A; PENNATI, M; GANDELLINI, P; ORLOTTI, NI; POMA, P; DAIDONE, MG; FOLINI, M; ZAFFARONI, N
Yin Yang 1 and Raf-1 Kinase Inhibitory Protein Status in Hepatocellular Carcinoma: Future Perspectives
2010-01-01 D'Alessandro, N; Giannitrapani, L; Labbozzetta, M; Poma, P; Inguglia, L; Florena, AM; Porcasi, R; Cervello, M; Montalto, G; Notarbartolo Di Villarosa, M
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile